Search clinical trials for: Drug：JS001, Intravenous infusion

Total 10468 results

Shanghai Junshi Bioscience Co., Ltd.

Completed

A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China

Recurrent/Refractory Malignant Lymphoma

China
Novartis Pharmaceuticals

Completed

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Pigmented Villonodular Synovitis | PVNS | Giant Cell Tumor of the Tendon Sheath | GCCTS | Tenosynovial Giant Cell Tumor Localized or Diffused Type | GCTS

United States, Switzerland
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Advanced Malignant Neoplasm

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Not yet recruiting

6MW3511 in Patients With Advanced Solid Tumor

Solid Tumors
The University of New South Wales

Completed

Faecal Microbiota Transplantation in Ulcerative Colitis (FOCUS)

Ulcerative Colitis | Inflammatory Bowel Disease

Australia
University of Florida

Completed

u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding

Angiodysplastic Bleeding

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

Essential Hypertension

United States
Erasme University Hospital

Completed

Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis

Severe Osteoporosis

Belgium
Navy General Hospital, Beijing
Xijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaborators

Unknown

WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction (WAIAMI)

Acute Myocardial Infarction
Medical University of Vienna
Klinik Favoriten

Recruiting

The Enteral Resuscitation In Intensive Care Pilot- Study (ERI)

Volume Overload | Hyperosmolality | Electrolyte Imbalance

Austria
University of Sao Paulo

Unknown

Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

Diabetes Mellitus, Insulin-Dependent

Brazil
The First Hospital of Jilin University

Completed

Phase Ib of Recombinant Human Albumin Injection

Ascites

China
Pfizer

Completed

Absolute Bioavailability Of Bosutinib

Healthy

United Kingdom
Rebecca Price
Gate Neurosciences, Inc

Not yet recruiting

Apimostinel + Automated Neurocognitive Training for Depression

Depression

United States
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

Hunter Syndrome

United States, Germany, Malaysia, Philippines, Thailand, Dominican Republic, Serbia, Vietnam
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis

Psoriasis

United States, Germany
Mahidol University
Siriraj Hospital

Recruiting

Safety of Short Hydration Method for Cisplatin Administration Compared With Conventional Hydration

Renal Insufficiency | Cis-Platinum Nephropathy

Thailand
University Hospital, Linkoeping
Region Örebro County; Blekingesjukhuset, Karlskrona

Completed

Glutamate for Metabolic Intervention in Coronary Surgery (GLUTAMICS)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Coronary Artery Bypass

Sweden
Children's Hospital of Chongqing Medical University

Unknown

Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndrome

China
The First Hospital of Jilin University

Completed

Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.

Ascites

China
Yufang Shi
Soochow University

Suspended

Mesenchymal Stem Cells Treat Liver Cirrhosis

Liver Cirrhosis

China
University Hospital, Brest
Roche Chugai

Completed

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

Polymyalgia Rheumatica

France
Cytori Therapeutics

Suspended

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Thermal Burn

United States
University of Sao Paulo

Recruiting

Optimizing Treatment on Idiopathic Inflammatory Myopathies

Idiopathic Inflammatory Myopathies

Brazil
Jinnah Hospital
Johns Hopkins University

Completed

Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients

Corona Virus Infection

Pakistan
University at Buffalo
American Diabetes Association

Completed

The Suppression of Toll Like Receptors by Insulin

Insulin Resistance

United States
University Hospital, Gentofte, Copenhagen

Recruiting

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension (GA-21)

PostPrandial Hypotension

Denmark
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
GlaxoSmithKline

Completed

GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults

Sepsis

United States, Canada, France, Netherlands, Russian Federation, Taiwan, Czechia, Estonia, Spain, Sweden, Thailand, Germany, Belgium, Israel, United Kingdom, Korea, Republic of, Portugal, Finland, Latvia, New Zealand, Malaysia, South... and more
Augusta University

Withdrawn

Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children

Cerebral Palsy

United States
Children's Hospital of Chongqing Medical University

Unknown

Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

China
Haukeland University Hospital
Ministry of Defence, Norway

Completed

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

Hemorrhagic Shock | Hypovolemic Shock

Norway
Children's Hospital of Chongqing Medical University

Unknown

Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

China
Sclnow Biotechnology Co., Ltd.

Not yet recruiting

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6
Gangnam Severance Hospital

Unknown

The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
Navy General Hospital, Beijing
Xijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaborators

Unknown

WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease (WANICHD)

Coronary Artery Disease
Polpharma Biologics S.A.

Completed

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® (Antelope)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
AstraZeneca
Quotient Sciences

Completed

Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594

Asthma

United Kingdom
Celularity Incorporated
Celgene Corporation

Completed

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Crohn's Disease

United States
Tigenix S.A.U.

Completed

Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers (CELLULA)

Sepsis

Netherlands
University Hospital, Gentofte, Copenhagen

Completed

Separate and Combined Extrapancreatic Effects of the Incretin Hormones (GA-19)

Pancreatectomy; Hyperglycemia

Denmark
Vinmec Research Institute of Stem Cell and Gene...

Completed

Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke

Ischemic Stroke

Vietnam
University of New Mexico
Sanofi

Completed

Comparative Trial Between 3 Types of Insulin Infusion Protocols

Hyperglycemia

United States
Pomeranian Medical University Szczecin

Unknown

Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates

Necrotizing Enterocolitis | Intracranial Hemorrhages | Retinopathy of Prematurity | Respiratory Distress Syndrome, Newborn | Anemia, Neonatal | Bronchopulmonary Dysplasia

Poland
Markus Zeitlinger

Recruiting

ZAVI APD ELF Protocol v2.2

Pneumonia | Peritonitis

Austria
The Cleveland Clinic

Terminated

An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome

Rett Syndrome

United States
Wroclaw Medical University

Recruiting

Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure (SOLVRED-AHF)

Heart Failure | Acute Heart Failure | Congestion

Poland
Pfizer

Completed

Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A

Hemophilia A

China
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis

Search clinical trials for: Drug：JS001, Intravenous infusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations